Muutke küpsiste eelistusi

E-raamat: Essential Oncology of the Lymphocyte

  • Formaat: PDF+DRM
  • Ilmumisaeg: 06-Dec-2012
  • Kirjastus: Springer London Ltd
  • Keel: eng
  • ISBN-13: 9781447114673
  • Formaat - PDF+DRM
  • Hind: 55,56 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: PDF+DRM
  • Ilmumisaeg: 06-Dec-2012
  • Kirjastus: Springer London Ltd
  • Keel: eng
  • ISBN-13: 9781447114673

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This book has been written from two points of view: firstly, from the viewpoint of those who are involved in the diagnosis and treatment of lymphoid malignancies, who must meet the challenge of integrating the new biological insights into their knowledge of these diseases; and secondly, from the viewpoint of those who are involved in basic biological approaches to malignancy and immunology, who wish to know more about the function of the lymphoid tissues and their malignant diseases. Neoplasia of lymphocytes is a focus for considering many of the most important biological advances impinging on cancer in the past two or three decades, because malignant lymphoproliferative diseases offer unequalled opportunities for studying many aspects of cancer. We probably know more about lymphocytes than other normal cells because of the ease with which they can be obtained. For the same reason we probably know more about malignant lymphocytes. One or other aspect of most of the momentous advances in biology of the past two or three decades has implications for lymphoid malignancies: hybridoma technology and the use of monoclonal antibodies, gene technology, the understanding of oncogenes and growth factors in the control of growth and differentiation, insights into causation of cancer by potent tumour promoters such as the phorbol esters and by viruses, and knowledge of the control of growth function of lymphocytes themselves. Conversely, many of the advances in understanding lym­ phocytic leukaemias and lymphomas have implications for other cancers.

Muu info

Springer Book Archives
1 Cancer Biology.- Development of Cancers from Single Cells.- Diversity
of Tumour Cells.- Differentiation of Malignant Cells.- 2 Derangement of the
Genome as a Cause of Cancer.- The Chromosomes.- Chromosomal Abnormalities in
Cancer.- Susceptibility to Chromosome Damage and Cancer.- Constitutional
Cytogenetic Abnormalities.- Fragile Sites.- 3 Derangements of the Mechanisms
Controlling Growth.- Cell Cycle.- Signal Transduction.- Immortalisation and
Transformation.- Mechanisms Leading to Autonomous Growth.- Differentiation
Arrest.- 4 Multiple Steps in the Genesis of a Cancer.- Initiation.-
Promotion.- Progression.- Conclusions.- 5 Multifactorial Aetiology of
Cancers.- Population and Familial Factors.- Carcinogens.- Radiation.-
Viruses.- Viruses in the Causation of Animal Cancers.- Viruses in the
Causation of Human Cancers.- Immunodepression and Immunosuppression.-
Prolonged Antigenic Stimulation.- 6 Oncogenes.- Translation Products of
Oncogenes.- Oncogene Products with Protein Kinase Activity.- GTP-binding
Oncogene Products.- Oncogenes Whose Products Bind to DNA.- Oncogene Product
with Growth Factor Activity.- Oncogenes Encoding Receptors for Growth
Factors.- Oncogenes Whose Products have Undefined Function.- Some Important
Non-human Oncogenes.- Aberrations of Oncogenes in Cancer.- Proteins
Homologous to Oncogene Products.- Transgenic Mice.- Oncogenes in Human
Tumours.- Multiple Oncogene Expression.- Conclusions.- 7 Growth Factors.-
Mechanisms of Action of Growth Factors.- Growth Factors in Malignant
Transformation.- Growth Factors for Haematopoietic Cells.- Chalones and Other
Antiproliferative Factors.- Conclusions.- 8 The Lymphoid Tissues.- Origin of
Lymphocytes.- T Lymphocytes.- B Lymphocytes.- NK, ADCC and
Lymphokine-activated Killer Cells.- Accessory Cells.- Activation of
Macrophages.- Lymphoid Organs and Immunological Function.- Lymphocyte
Circulation.- Organisation of Immunological Function.- 9 The Major
Histocompatibility Complex.- Tissue Distribution of MHC Products.- MHC Gene
Products and Their Specificities.- Immunoregulatory Function of the MHC.-
Mixed Lymphocyte Reaction.- Graft Versus Host Reaction.- Association of
Diseases with MHC Phenotype.- Conclusions.- 10 T Cell Differentiation.- The
Thymus.- T Lymphocytes in Bone Marrow.- T Cells in Lymph Nodes.- T Cell
Subsets.- T Cell Receptor.- Genetic Mechanisms in T Cell Differentiation.- T
Cell Activation.- Signal Transduction in T Cell Activation.- 11 B Cell
Differentiation.- Antigen-independent B Cell Differentiation.- B Lymphocyte
Differentiation in Postnatal Life.- Antigen-dependent B Cell
Differentiation.- B Cell Subsets.- Immunoglobulin.- Genetic Mechanisms in B
Cell Differentiation.- 12 B Cell Activation.- T Cells in B Cell Activation.-
Accessory Cells in B Cell Activation.- B Cell Activation by Cross-linking
Immunoglobulin.- Soluble Factors in B Cell Activation.- Cellular Events in B
Lymphocyte Activation.- Conclusions.- 13 Immunoregulatory Mechanisms.-
Systems Controlling Immunological Function.- Suppressor Mechanisms.-
Idiotypes.- Immunological Tolerance.- Regulatory Mechanisms in B Cell
Malignancies.- 14 Technology of Investigation and Diagnosis.- Hybridoma
Technology and Monoclonal Antibodies.- Gene Cloning.- Gene Probing.-
Immunodiagnostic Methods.- Immunological Methods.- Immunohistochemical
Methods.- Histochemical Stains.- Flow Cytometry.- Ultrastructural Analysis.-
Conclusions.- 15 B Cell Neoplasia.- Immunological Abnormalities in Lymphoid
Malignancies.- Chromosomal Abnormalities in B Cell Malignancies.- Oncogene
Activation in B Cell Neoplasia.- Immunoglobulin Gene Rearrangements.- 16 B
Cell Leukaemias.- Acute Lymphoblastic Leukaemia.- B-Chronic Lymphocytic
Leukaemia.- B Cell Prolymphocytic Leukaemia.- Hairy Cell Leukaemia.- Chronic
Cold Agglutinin Disease.- Lymphoplasmacytoid Lymphoma.- Plasma Cell
Dyscrasias.- 17 B Cell Lymphomas.- B Cell Lymphomas of the Deep Cortex.- B
Cell Lymphomas of the Superficial Cortex.- B Cell Lymphomas of the Medulla:
Plasmacytoma.- Undifferentiated B Cell Lymphomas.- Extranodal B Cell
Lymphomas.- Hodgkins Disease.- 18 T Cell Neoplasia.- Chromosomal
Abnormalities in T Cell Malignancies.- Gene Rearrangements in T Cell
Malignancies.- 19 T Cell Leukaemias and Lymphomas.- T Cell Neoplasms of the
Bone Marrow Compartment.- T Cell Neoplasms of the Thymic Compartment.- T Cell
Neoplasms of the Peripheral Compartment.- 20 Treatment, Treatment Failure and
Future Possibilities.- Treatment Failure Exemplified by Lymphocytic
Leukaemia.- Immunotherapy.- Cytokines and Other Biological Agents.- New Drugs
and Other Treatments.- Conclusions.